Evidence map›Paper›PMID 10333939›Full record

SynthesisDiabetes care1999

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

M Coutinho, H C Gerstein, Y Wang, S Yusuf

3 registry-linked trialsAbstract readComparative StudyMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Diabetes care, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 433 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
433citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06767774 phase4recruitingstarted 2025, after this paper: background citation

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus in Prediabetic Patients With Atherosclerotic Cardiovascular Disease

Ran2025Enrolled2,000Registered outcomes13Posted comparisons0ConditionsASCVD, Diabetes, StatinArmsCombination therapy, High intensity statin monotherapy
Open the trial in the graph
NCT01524159 nacompletednot on this mapstarted 2011, after this paper: background citation

Bromelain and Cardiovascular Risk Factors in Diabetes

TypeinterventionalSponsorHebei Yiling HospitalRan2011 to 2011Enrolled72ConditionsCardiovascular Disease.Armsbromelain capsule, placebo (wheat starch)
NCT06256614 recruitingnot on this mapstarted 2024, after this paper: background citation

Washed Microbiota Transplantation for Type 1 Diabetes Mellitus: a Real World Research

TypeobservationalSponsorThe Second Hospital of Nanjing Medical UniversityRan2024 to 2029Enrolled50ConditionsType 1 DiabetesArmsWMT
3 · Its place in the literature

Who cites it

433 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes.Translational research : the journal of laboratory and clinical medicine · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

373 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

M CoutinhoPreventive Cardiology and Therapeutics Research Program, Hamilton Civic Hospitals Research Center, Hamilton, Ontario, Canada.
H C Gerstein
Y Wang
S Yusuf

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the relationship between nondiabetic glucose levels and cardio vascular risk. RESEARCH DESIGN AND

methodsThree independent searches using MEDLINE (1966-1996), followed by a manual search of the references from each retrieved article, were conducted by two physicians and one medical librarian. Data had to be reported in at least three quantiles or intervals so that the nature of the relationship between glucose and cardiovascular events (i.e., linear or nonlinear) could be explored, and to ensure that any incremental cardiovascular risk was consistent across quantiles or intervals.

resultsAnalyzed studies comprised 95,783 people (94% male) who had 3,707 cardiovascular events over 12.4 years (1,193,231 person-years). Studies reporting fasting glucose levels (n = 6), 2-h glucose levels (n = 7), 1-h glucose levels (n = 5), and casual glucose levels (n = 4) were included. The glucose load used varied from 50 to 100 g. The highest glucose interval for most studies included glucose values in the diabetic range. The relationship between glucose levels and the risk of a cardiovascular event was modeled for each study and the beta-coefficients were combined. Compared with a glucose level of 4.2 mmol/l (75 mg/dl), a fasting and 2-h glucose level of 6.1 mmol/dl (110 mg/dl) and 7.8 mmol/l (140 mg/dl) was associated with a relative cardiovascular event risk of 1.33 (95% CI 1.06-1.67) and 1.58 (95% CI 1.19-2.10), respectively.

conclusionsThe progressive relationship between glucose levels and cardiovascular risk extends below the diabetic threshold.

Indexed as

AdultAgedBlood GlucoseCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusFemaleGlucose IntoleranceGlucose Tolerance TestHumansIncidenceMaleMiddle AgedRegression AnalysisBlood Glucose

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.